This study aimed to evaluate the relationship between serum ERBB2, NRG4, and MIG6 levels and tumor characteristics, overall survival, and tumor recurrence to determine the potential prognostic value of these signaling molecules for HCC. The gene discussed is ERBB2; the disease is neoplasm.